Non-coding landscapes of colorectal cancer

Table 5 Diagnostic and prognostic circulating non-coding RNAs in colorectal cancer

Clinical feature	Oncogene ncRNAs	Tumor suppressor ncRNAs	PMID
Diagnostic	miR-17-3p, miR-92a, miR-29a, miR-18a, miR-19a, miR-19b, miR-15b, miR-335, miR-221, exo-let-7a, exo-miR-1229, exo-miR-1246, exo-miR-150, exo-miR-21, exo-miR-223, exo-miR-23a, miR-378, miR-21, CRNDE, miR-155, miR-200c, miR-210	miR-601, miR-760, miR-143	19201770, 19876917, 23267864, 22970209, 20880178, 24705249, 25547322, 22868372, 22393467, 24310813
Metastasis detection	miR-29a, miR-21		22018950, 23704278
Survival	miR-141, miR-221, miR-21		21445232, 20880178, 23704278
Tumour size	miR-21		23704278
Tumour stage	miR-141		21445232

Cancer-related phenotypes that may be predicted by expression analysis of plasma/serum circulating oncogenic and tumor suppressive non-coding RNAs (ncRNAs). Exo-miR: MiRNAs purified from exosomes.